首页> 中文期刊>临床肺科杂志 >N-乙酰半胱氨酸治疗老年吸入性肺炎的疗效观察

N-乙酰半胱氨酸治疗老年吸入性肺炎的疗效观察

     

摘要

目的 观察N-乙酰半胱氨酸治疗老年吸入性肺炎疗效和安全性.方法 将68例老年吸入性肺炎的患者随机分为治疗组和对照组,两组均给予常规治疗,治疗组加用N-乙酰半胱氨酸,然后比较两组血氧饱和度恢复时间、呼吸困难改善时间、吸痰次数、病灶吸收显效时间及平均住院天数等方面的差异.结果 治疗结束时,两组血氧饱和度恢复时间、呼吸困难改善时间、吸痰次数、病灶吸收显效时间及平均住院天数等方面差异有显著性(P<0.01),且安全性较高.结论 应用N-乙酰半胱氨酸治疗老年吸入性肺炎能明显改善患者的临床症状,缩短疗程,改善预后,无明显副反应.%Objective To observe the efficacy and safety of tylcysteine in treatment of elderly aspiration pneumonia. Methods 68 elderly patients with aspiration pneumonia were randomly divided into treatment group and control group, who were given conventional treatment, while the treatment group plus NAC, and then the blood oxygen saturation recovery time, dyspnea improvement time, times of aspiration of sputum, foci absorption time and the average hospital stay time were compared between the two groups. Results The blood oxygen saturation recovery time, dyspnea improvement time, times of aspiration of sputum, foci absorption time and the average hospital stay time significantly improved in the treatment group compared with the control group, with significant differences(P <0. 01) , moreover, N-acetylcysteine in the treatment of elderly patients with aspiration pneumonia had higher security. Conclusion The inhalation of ace-tylcysteine in treatment of elderly patients with pneumonia can significantly improve the clinical symptoms, shorten the course of treatment, improve outcomes without significant side effects.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号